Contact
searchSearch
HMP Global

Meet the Experts

headshot of Doug Devens Doug Devens
headshot of Kris Flinn Kris Flinn
Headshot of Jay Merkel Jay Merkel
Headshot of Susan Paquette Susan Paquette
headshot of Lennart Stalder Lennart Stadler
Headshot of Anikó Szekér Anikó Szekér

 

Click here to learn more

SmartTrak x Wound Care Collaboration

Featured Commentaries

Market Responds to Final MAC LCDs
Blog
Market Responds to Final MAC LCDs
01/08/2025
This blog was originally posted on SmartTrak's website on December 31, 2024: https://blog.smarttrak.com/market-responds-to-final-mac-lcds. Reposted with permission. SmartTRAK looks at the market’s response to the recently finalized...
This blog was originally posted on SmartTrak's website on December 31, 2024: https://blog.smarttrak.com/market-responds-to-final-mac-lcds. Reposted with permission. SmartTRAK looks at the market’s response to the recently finalized...
This blog was originally...
01/08/2025
Wound Care
Facing the Payback Crisis: Challenges Threatening Italy’s Medical Device Sector
Blog
Facing the Payback Crisis: Challenges Threatening Italy’s Medical Device Sector
11/26/2024
In an interview with SmartTRAK, Gennaro Broya de Lucia, president of the National Board of Directors at PMI Sanità, offers a comprehensive summary of the challenges for the medical device market in Italy, which places hundreds of companies at...
In an interview with SmartTRAK, Gennaro Broya de Lucia, president of the National Board of Directors at PMI Sanità, offers a comprehensive summary of the challenges for the medical device market in Italy, which places hundreds of companies at...
In an interview with SmartTRAK,...
11/26/2024
Wound Care
Reimbursement Changes: Wound Dressings Under Threat in Germany
Blog
Reimbursement Changes: Wound Dressings Under Threat in Germany
10/01/2024
In an interview with SmartTRAK, Dr. Willi Schnorpfeil, an expert in reimbursement strategies, offers a comprehensive overview of the regulatory changes for advanced wound care products in Germany, which pose a potential threat to both market...
In an interview with SmartTRAK, Dr. Willi Schnorpfeil, an expert in reimbursement strategies, offers a comprehensive overview of the regulatory changes for advanced wound care products in Germany, which pose a potential threat to both market...
In an interview with SmartTRAK,...
10/01/2024
Wound Care
Skin Substitute Market Rocked by DOJ Investigations
Blog
Skin Substitute Market Rocked by DOJ Investigations
08/08/2024
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg in services billed to Medicare via the Physician Fee Schedule.
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg in services billed to Medicare via the Physician Fee Schedule.
SmartTRAK believes the billions...
08/08/2024
Wound Care
Medicare Administrative Contractors' (MACs) LCD Changes: Impact on Skin Substitutes/CTPs
Blog
Medicare Administrative Contractors' (MACs) LCD Changes: Impact on Skin Substitutes/CTPs
05/29/2024
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
All seven MACs, in a united...
05/29/2024
Wound Care
Vaporox Company Spotlight
Blog
Vaporox Company Spotlight
05/07/2024
This blog was originally posted on SmartTrak's website on May 2, 2024: https://blog.smarttrak.com/vaporox-company-spotlight. Reposted with permission. New leadership at Vaporox to launch a second generation of vaporous hyperoxia...
This blog was originally posted on SmartTrak's website on May 2, 2024: https://blog.smarttrak.com/vaporox-company-spotlight. Reposted with permission. New leadership at Vaporox to launch a second generation of vaporous hyperoxia...
This blog was originally...
05/07/2024
Wound Care
Swedish Wound Care Companies – You Win Some, You Lose Some
Blog
Swedish Wound Care Companies – You Win Some, You Lose Some
04/10/2024
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Reposted with permission. It is difficult to make it as a small to midsize...
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Reposted with permission. It is difficult to make it as a small to midsize...
This blog was originally...
04/10/2024
Wound Care
Preview Image
Blog
What Impact will GLP-1 Agonists have on Chronic Wounds?
03/18/2024
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
With many believing that GLP-1...
03/18/2024
Wound Care
Preview Image
Partner Content
Advanced Wound Dressings: 2024 Market Outlook
03/05/2024
SmartTRAK forecasts the WW Advanced Wound Dressing Market will grow at a 5-year CAGR of +5.2%. The market grew +5.2% in Q323 and +5.6% in the first three quarters of 2023.
SmartTRAK forecasts the WW Advanced Wound Dressing Market will grow at a 5-year CAGR of +5.2%. The market grew +5.2% in Q323 and +5.6% in the first three quarters of 2023.
SmartTRAK forecasts the WW...
03/05/2024
Wound Care
Wound Debridement 2024 Outlook
Partner Content
Wound Debridement 2024 Outlook
02/12/2024

SmartTRAK

SmartTRAK
With the eyes of the wound care world focused on the markets for Skin Substitutes and Antimicrobials, SmartTRAK discusses how 2024 could be a disruptive year for Debridement.
With the eyes of the wound care world focused on the markets for Skin Substitutes and Antimicrobials, SmartTRAK discusses how 2024 could be a disruptive year for Debridement.
With the eyes of the wound care...
02/12/2024
Wound Care
Market Responds to Final MAC LCDs
Blog
Market Responds to Final MAC LCDs
01/08/2025
This blog was originally posted on SmartTrak's website on December 31, 2024: https://blog.smarttrak.com/market-responds-to-final-mac-lcds. Reposted with permission. SmartTRAK looks at the market’s response to the recently finalized...
This blog was originally posted on SmartTrak's website on December 31, 2024: https://blog.smarttrak.com/market-responds-to-final-mac-lcds. Reposted with permission. SmartTRAK looks at the market’s response to the recently finalized...
This blog was originally...
01/08/2025
Wound Care
Facing the Payback Crisis: Challenges Threatening Italy’s Medical Device Sector
Blog
Facing the Payback Crisis: Challenges Threatening Italy’s Medical Device Sector
11/26/2024
In an interview with SmartTRAK, Gennaro Broya de Lucia, president of the National Board of Directors at PMI Sanità, offers a comprehensive summary of the challenges for the medical device market in Italy, which places hundreds of companies at...
In an interview with SmartTRAK, Gennaro Broya de Lucia, president of the National Board of Directors at PMI Sanità, offers a comprehensive summary of the challenges for the medical device market in Italy, which places hundreds of companies at...
In an interview with SmartTRAK,...
11/26/2024
Wound Care
Reimbursement Changes: Wound Dressings Under Threat in Germany
Blog
Reimbursement Changes: Wound Dressings Under Threat in Germany
10/01/2024
In an interview with SmartTRAK, Dr. Willi Schnorpfeil, an expert in reimbursement strategies, offers a comprehensive overview of the regulatory changes for advanced wound care products in Germany, which pose a potential threat to both market...
In an interview with SmartTRAK, Dr. Willi Schnorpfeil, an expert in reimbursement strategies, offers a comprehensive overview of the regulatory changes for advanced wound care products in Germany, which pose a potential threat to both market...
In an interview with SmartTRAK,...
10/01/2024
Wound Care
Skin Substitute Market Rocked by DOJ Investigations
Blog
Skin Substitute Market Rocked by DOJ Investigations
08/08/2024
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg in services billed to Medicare via the Physician Fee Schedule.
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg in services billed to Medicare via the Physician Fee Schedule.
SmartTRAK believes the billions...
08/08/2024
Wound Care
Medicare Administrative Contractors' (MACs) LCD Changes: Impact on Skin Substitutes/CTPs
Blog
Medicare Administrative Contractors' (MACs) LCD Changes: Impact on Skin Substitutes/CTPs
05/29/2024
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/CTP use for DFUs and VLUs. SmartTRAK looks at the potential impact on the market.
All seven MACs, in a united...
05/29/2024
Wound Care
Vaporox Company Spotlight
Blog
Vaporox Company Spotlight
05/07/2024
This blog was originally posted on SmartTrak's website on May 2, 2024: https://blog.smarttrak.com/vaporox-company-spotlight. Reposted with permission. New leadership at Vaporox to launch a second generation of vaporous hyperoxia...
This blog was originally posted on SmartTrak's website on May 2, 2024: https://blog.smarttrak.com/vaporox-company-spotlight. Reposted with permission. New leadership at Vaporox to launch a second generation of vaporous hyperoxia...
This blog was originally...
05/07/2024
Wound Care
Swedish Wound Care Companies – You Win Some, You Lose Some
Blog
Swedish Wound Care Companies – You Win Some, You Lose Some
04/10/2024
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Reposted with permission. It is difficult to make it as a small to midsize...
This blog was originally posted on SmartTrak's website on April 2, 2024: https://blog.smarttrak.com/swedish-wound-care-companies-you-win-some-you-lose-some. Reposted with permission. It is difficult to make it as a small to midsize...
This blog was originally...
04/10/2024
Wound Care
Preview Image
Blog
What Impact will GLP-1 Agonists have on Chronic Wounds?
03/18/2024
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what impact their use could have on the market for wound care
With many believing that GLP-1...
03/18/2024
Wound Care
Preview Image
Partner Content
Advanced Wound Dressings: 2024 Market Outlook
03/05/2024
SmartTRAK forecasts the WW Advanced Wound Dressing Market will grow at a 5-year CAGR of +5.2%. The market grew +5.2% in Q323 and +5.6% in the first three quarters of 2023.
SmartTRAK forecasts the WW Advanced Wound Dressing Market will grow at a 5-year CAGR of +5.2%. The market grew +5.2% in Q323 and +5.6% in the first three quarters of 2023.
SmartTRAK forecasts the WW...
03/05/2024
Wound Care
Wound Debridement 2024 Outlook
Partner Content
Wound Debridement 2024 Outlook
02/12/2024

SmartTRAK

SmartTRAK
With the eyes of the wound care world focused on the markets for Skin Substitutes and Antimicrobials, SmartTRAK discusses how 2024 could be a disruptive year for Debridement.
With the eyes of the wound care world focused on the markets for Skin Substitutes and Antimicrobials, SmartTRAK discusses how 2024 could be a disruptive year for Debridement.
With the eyes of the wound care...
02/12/2024
Wound Care

SmartTRAK Wound Market Analyses

January 8: According to the SmartTRAK Financial Dashboard, for Q324, the US Advanced Wound Care Market grew +39.1%, led by the Biologics segment, which was up +59.0% YoY. Advanced Dressings increased up +7.2%, while External Devices came in +4.4%.

December 30: According to the SmartTRAK Financial Dashboard, the US CTP/Skin Substitute market grew 64.0% in Q324 compared to Q323. Three market leaders (BioLab Sciences, Legacy Medical and Extremity Care) combined represent 43.5% of the market share.

For more market analyses, click here.

Wound Care Updates

News
Avita Medical
01/09/2025
AVITA Medical now expects Q424 commercial revenue to be ~$18.4MM, reflecting growth of around +30% over Q423. Previously provided Q424 guidance was in the range of $22.3MM to $24.3MM. Results were primarily impacted by slower-than-expected...
AVITA Medical now expects Q424 commercial revenue to be ~$18.4MM, reflecting growth of around +30% over Q423. Previously provided Q424 guidance was in the range of $22.3MM to $24.3MM. Results were primarily impacted by slower-than-expected...
AVITA Medical now expects Q424...
01/09/2025
Wound Care
News
Mölnlycke
01/09/2025
Mölnlycke invested $8M in Siren, a healthcare tech company specializing in temperature-sensing textiles to prevent DFUs. This partnership aims to improve patient outcomes, lower healthcare costs, and support healthcare providers.
Mölnlycke invested $8M in Siren, a healthcare tech company specializing in temperature-sensing textiles to prevent DFUs. This partnership aims to improve patient outcomes, lower healthcare costs, and support healthcare providers.
Mölnlycke invested $8M in Siren,...
01/09/2025
Wound Care
News
Smith+Nephew
01/09/2025
An economic analysis found that for a cohort of 1,000 patients, the usage of multilayer, silicone-adhesive PU foam dressings for prevention would result in 80 less hospital-acquired pressure ulcers (HAPUs), saving ~$187 (€179) per patient for...
An economic analysis found that for a cohort of 1,000 patients, the usage of multilayer, silicone-adhesive PU foam dressings for prevention would result in 80 less hospital-acquired pressure ulcers (HAPUs), saving ~$187 (€179) per patient for...
An economic analysis found that...
01/09/2025
Wound Care
News
CMS Publishes Jan 2025 ASP Files
01/09/2025
CMS has published the Jan-Mar 2025 quarterly drug pricing files with payment limits for some Part B-covered drugs. Eighty-nine skin substitutes had published pricing, down 15 from the previous quarter. New additions included 2 codes for...
CMS has published the Jan-Mar 2025 quarterly drug pricing files with payment limits for some Part B-covered drugs. Eighty-nine skin substitutes had published pricing, down 15 from the previous quarter. New additions included 2 codes for...
CMS has published the Jan-Mar...
01/09/2025
Wound Care
News
MolecuLight
01/09/2025
MolecuLight announced it has secured a $27.5MM investment from Hayfin Capital Management LLP, a leading healthcare institution. The significant investment will enable MolecuLight to further accelerate commercialization in the US, Canada, and...
MolecuLight announced it has secured a $27.5MM investment from Hayfin Capital Management LLP, a leading healthcare institution. The significant investment will enable MolecuLight to further accelerate commercialization in the US, Canada, and...
MolecuLight announced it has...
01/09/2025
Wound Care
News
TWO2 Multi-Patch System - AOTI
01/09/2025
AOTI has initiated a 212-patient RCT to evaluate cyclical Topical Wound Oxygen Therapy (TWO2) in the treatment of chronic VLUs with a primary outcome of incidence of wound closures within 16 weeks. Est study completion is Dec 2027....
AOTI has initiated a 212-patient RCT to evaluate cyclical Topical Wound Oxygen Therapy (TWO2) in the treatment of chronic VLUs with a primary outcome of incidence of wound closures within 16 weeks. Est study completion is Dec 2027....
AOTI has initiated a 212-patient...
01/09/2025
Wound Care
News
ABCB5+ - Rheacell
01/09/2025
Rheacell announced it has received approval from the EMA for its blinded, multi-centric Phase-3 trial (NCT06489028) evaluating allo-APZ2-CVU in patients with chronic venous ulcers (CVU). The pivotal trial will take place in both the EU and US...
Rheacell announced it has received approval from the EMA for its blinded, multi-centric Phase-3 trial (NCT06489028) evaluating allo-APZ2-CVU in patients with chronic venous ulcers (CVU). The pivotal trial will take place in both the EU and US...
Rheacell announced it has...
01/09/2025
Wound Care
News
Airos Medica
01/08/2025
AIROS Medical received FDA 510(k) clearance for Artaira Arterial Compression Device which is an intermittent pneumatic compression device for use in the lower extremities with timed compression. ACI Medical’s ArtAssist device was used as a...
AIROS Medical received FDA 510(k) clearance for Artaira Arterial Compression Device which is an intermittent pneumatic compression device for use in the lower extremities with timed compression. ACI Medical’s ArtAssist device was used as a...
AIROS Medical received FDA...
01/08/2025
Wound Care
News
SurgiClose - Kerecis 
12/30/2024
Kerecis announced the availability of SurgiClose Silicone, which combines a fish skin graft and silicone backing to efficiently treat surgical and trauma wounds. The new product is available in two variations: one with borders and one with...
Kerecis announced the availability of SurgiClose Silicone, which combines a fish skin graft and silicone backing to efficiently treat surgical and trauma wounds. The new product is available in two variations: one with borders and one with...
Kerecis announced the...
12/30/2024
Wound Care
News
Diabetic Foot Infections
12/30/2024
A retrospective chart review of 294 hospitalized patients with moderate to severe diabetic foot infections (DFIs) found that re-infection is common. Key risk factors include osteomyelitis, non-healing wounds, prolonged wound healing, use of...
A retrospective chart review of 294 hospitalized patients with moderate to severe diabetic foot infections (DFIs) found that re-infection is common. Key risk factors include osteomyelitis, non-healing wounds, prolonged wound healing, use of...
A retrospective chart review of...
12/30/2024
Wound Care
News
Avita Medical
01/09/2025
AVITA Medical now expects Q424 commercial revenue to be ~$18.4MM, reflecting growth of around +30% over Q423. Previously provided Q424 guidance was in the range of $22.3MM to $24.3MM. Results were primarily impacted by slower-than-expected...
AVITA Medical now expects Q424 commercial revenue to be ~$18.4MM, reflecting growth of around +30% over Q423. Previously provided Q424 guidance was in the range of $22.3MM to $24.3MM. Results were primarily impacted by slower-than-expected...
AVITA Medical now expects Q424...
01/09/2025
Wound Care
News
Mölnlycke
01/09/2025
Mölnlycke invested $8M in Siren, a healthcare tech company specializing in temperature-sensing textiles to prevent DFUs. This partnership aims to improve patient outcomes, lower healthcare costs, and support healthcare providers.
Mölnlycke invested $8M in Siren, a healthcare tech company specializing in temperature-sensing textiles to prevent DFUs. This partnership aims to improve patient outcomes, lower healthcare costs, and support healthcare providers.
Mölnlycke invested $8M in Siren,...
01/09/2025
Wound Care
News
Smith+Nephew
01/09/2025
An economic analysis found that for a cohort of 1,000 patients, the usage of multilayer, silicone-adhesive PU foam dressings for prevention would result in 80 less hospital-acquired pressure ulcers (HAPUs), saving ~$187 (€179) per patient for...
An economic analysis found that for a cohort of 1,000 patients, the usage of multilayer, silicone-adhesive PU foam dressings for prevention would result in 80 less hospital-acquired pressure ulcers (HAPUs), saving ~$187 (€179) per patient for...
An economic analysis found that...
01/09/2025
Wound Care
News
CMS Publishes Jan 2025 ASP Files
01/09/2025
CMS has published the Jan-Mar 2025 quarterly drug pricing files with payment limits for some Part B-covered drugs. Eighty-nine skin substitutes had published pricing, down 15 from the previous quarter. New additions included 2 codes for...
CMS has published the Jan-Mar 2025 quarterly drug pricing files with payment limits for some Part B-covered drugs. Eighty-nine skin substitutes had published pricing, down 15 from the previous quarter. New additions included 2 codes for...
CMS has published the Jan-Mar...
01/09/2025
Wound Care
News
MolecuLight
01/09/2025
MolecuLight announced it has secured a $27.5MM investment from Hayfin Capital Management LLP, a leading healthcare institution. The significant investment will enable MolecuLight to further accelerate commercialization in the US, Canada, and...
MolecuLight announced it has secured a $27.5MM investment from Hayfin Capital Management LLP, a leading healthcare institution. The significant investment will enable MolecuLight to further accelerate commercialization in the US, Canada, and...
MolecuLight announced it has...
01/09/2025
Wound Care
News
TWO2 Multi-Patch System - AOTI
01/09/2025
AOTI has initiated a 212-patient RCT to evaluate cyclical Topical Wound Oxygen Therapy (TWO2) in the treatment of chronic VLUs with a primary outcome of incidence of wound closures within 16 weeks. Est study completion is Dec 2027....
AOTI has initiated a 212-patient RCT to evaluate cyclical Topical Wound Oxygen Therapy (TWO2) in the treatment of chronic VLUs with a primary outcome of incidence of wound closures within 16 weeks. Est study completion is Dec 2027....
AOTI has initiated a 212-patient...
01/09/2025
Wound Care
News
ABCB5+ - Rheacell
01/09/2025
Rheacell announced it has received approval from the EMA for its blinded, multi-centric Phase-3 trial (NCT06489028) evaluating allo-APZ2-CVU in patients with chronic venous ulcers (CVU). The pivotal trial will take place in both the EU and US...
Rheacell announced it has received approval from the EMA for its blinded, multi-centric Phase-3 trial (NCT06489028) evaluating allo-APZ2-CVU in patients with chronic venous ulcers (CVU). The pivotal trial will take place in both the EU and US...
Rheacell announced it has...
01/09/2025
Wound Care
News
Airos Medica
01/08/2025
AIROS Medical received FDA 510(k) clearance for Artaira Arterial Compression Device which is an intermittent pneumatic compression device for use in the lower extremities with timed compression. ACI Medical’s ArtAssist device was used as a...
AIROS Medical received FDA 510(k) clearance for Artaira Arterial Compression Device which is an intermittent pneumatic compression device for use in the lower extremities with timed compression. ACI Medical’s ArtAssist device was used as a...
AIROS Medical received FDA...
01/08/2025
Wound Care
News
SurgiClose - Kerecis 
12/30/2024
Kerecis announced the availability of SurgiClose Silicone, which combines a fish skin graft and silicone backing to efficiently treat surgical and trauma wounds. The new product is available in two variations: one with borders and one with...
Kerecis announced the availability of SurgiClose Silicone, which combines a fish skin graft and silicone backing to efficiently treat surgical and trauma wounds. The new product is available in two variations: one with borders and one with...
Kerecis announced the...
12/30/2024
Wound Care
News
Diabetic Foot Infections
12/30/2024
A retrospective chart review of 294 hospitalized patients with moderate to severe diabetic foot infections (DFIs) found that re-infection is common. Key risk factors include osteomyelitis, non-healing wounds, prolonged wound healing, use of...
A retrospective chart review of 294 hospitalized patients with moderate to severe diabetic foot infections (DFIs) found that re-infection is common. Key risk factors include osteomyelitis, non-healing wounds, prolonged wound healing, use of...
A retrospective chart review of...
12/30/2024
Wound Care

About This Partnership

Wound Care Learning Network has partnered with SmartTRAK, the global leader in business intelligence for the life sciences industry, to provide market data and analyses in wound care.  Through rich ongoing updates and comprehensive expert analyses, wound care professionals will stay ahead of evolving market trends and conditions of interest to the wound care community.

For more information on SmartTRAK resources and services, click here.

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use